Maha Abdeladhim Selected Research

Salivary Proteins and Peptides

1/2022	Some Good and Some Bad: Sand Fly Salivary Proteins in the Control of Leishmaniasis and in Autoimmunity.
12/2020	Implicating bites from a leishmaniasis sand fly vector in the loss of tolerance in pemphigus.
1/2020	Immunity to vector saliva is compromised by short sand fly seasons in endemic regions with temperate climates.
1/2018	Phlebotomus papatasi Yellow-Related and Apyrase Salivary Proteins Are Candidates for Vaccination against Human Cutaneous Leishmaniasis.
1/2016	Intradermal Immunization of Leishmania donovani Centrin Knock-Out Parasites in Combination with Salivary Protein LJM19 from Sand Fly Vector Induces a Durable Protective Immune Response in Hamsters.
1/2016	Molecular Diversity between Salivary Proteins from New World and Old World Sand Flies with Emphasis on Bichromomyia olmeca, the Sand Fly Vector of Leishmania mexicana in Mesoamerica.
6/2015	A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates.
2/2015	Severity of old world cutaneous leishmaniasis is influenced by previous exposure to sandfly bites in Saudi Arabia.
1/2015	Validation of Recombinant Salivary Protein PpSP32 as a Suitable Marker of Human Exposure to Phlebotomus papatasi, the Vector of Leishmania major in Tunisia.
1/2012	Updating the salivary gland transcriptome of Phlebotomus papatasi (Tunisian strain): the search for sand fly-secreted immunogenic proteins for humans.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maha Abdeladhim Research Topics

Disease

9	Leishmaniasis 01/2023 - 01/2012
7	Bites and Stings (Sting) 01/2024 - 01/2012
4	Infections 01/2017 - 05/2011
3	Pemphigus (Pemphigus Vulgaris) 01/2022 - 03/2016
3	Cutaneous Leishmaniasis 01/2018 - 06/2015
2	Hypersensitivity (Allergy) 10/2019 - 01/2017
1	Neoplasms (Cancer) 01/2022
1	Skin Diseases (Skin Disease) 01/2022
1	Anaphylaxis (Anaphylactic Shock) 10/2019
1	Hypothermia 10/2019
1	Hemorrhage 01/2017
1	Hemophilia A (Haemophilia) 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 03/2016
1	Pemphigus and fogo selvagem 03/2016
1	Visceral Leishmaniasis (Kala Azar) 01/2016
1	Rheumatoid Arthritis 12/2014
1	Celiac Disease (Celiac Sprue) 04/2012
1	Atrophy 04/2012
1	Type 2 Diabetes Mellitus (MODY) 06/2010
1	Inflammation (Inflammations) 06/2009

Drug/Important Bio-Agent (IBA)

11	Salivary Proteins and PeptidesIBA 01/2022 - 01/2012
8	VaccinesIBA 01/2023 - 05/2011
7	Proteins (Proteins, Gene)FDA Link 10/2019 - 01/2012
5	AntibodiesIBA 01/2022 - 01/2012
4	AntigensIBA 10/2019 - 01/2012
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2015
2	AutoantigensIBA 12/2020 - 03/2016
2	Interleukin-15 (Interleukin 15)IBA 04/2012 - 06/2009
1	Hematoxylin (Haematoxylon)IBA 01/2024
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2024
1	Leishmaniasis VaccinesIBA 01/2022
1	DesmogleinsIBA 12/2020
1	ovalbumin-alumIBA 10/2019
1	Chimeric Antigen ReceptorsIBA 10/2019
1	AllergensIBA 10/2019
1	Immunoglobulin E (IgE)IBA 10/2019
1	OvalbuminIBA 10/2019
1	Apyrase (ATP Diphosphatase)IBA 01/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Neutralizing AntibodiesIBA 01/2017
1	Factor VIII (Coagulation Factor VIII)IBA 01/2017
1	Complement System Proteins (Complement)IBA 01/2017
1	AutoantibodiesIBA 03/2016
1	Immunoglobulin G (IgG)IBA 03/2016
1	Desmoglein 1IBA 03/2016
1	Interleukin-17 (Interleukin 17)IBA 12/2014
1	InterleukinsIBA 04/2012
1	CytokinesIBA 04/2012
1	Malathion (Karbofos)FDA LinkGeneric 06/2010

Therapy/Procedure

2	Therapeutics 01/2022 - 01/2017